BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Aljiffry M, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol 2009; 15(34): 4240-4262 [PMID: 19750567 DOI: 10.3748/wjg.15.4240]
URL: https://www.wjgnet.com/1007-9327/full/v15/i34/4240.htm
Number Citing Articles
1
Jacob Schmidt, Weronika Kuzyniak, Janine Berkholz, Gustav Steinemann, Racheal Ogbodu, Bj�rn Hoffmann, Geraldine Nouailles, Ayşe G�rek, Bianca Nitzsche, Michael H�pfner. Novel zinc‑ and silicon‑phthalocyanines as photosensitizers for photodynamic therapy of cholangiocarcinomaInternational Journal of Molecular Medicine 2018;  doi: 10.3892/ijmm.2018.3620
2
Sun-young Park, Jin Hyoung Kim, Hyung Jin Won, Yong Moon Shin, Pyo Nyun Kim. Radiofrequency Ablation of Hepatic Metastases After Curative Resection of Extrahepatic CholangiocarcinomaAmerican Journal of Roentgenology 2011; 197(6): W1129 doi: 10.2214/AJR.11.6420
3
Kazuto Kozaka, Satoshi Kobayashi, Hiroyuki Takamura, Yasunori Sato, Azusa Kitao, Dai Inoue, Norihide Yoneda, Hidehiro Tajima, Seigo Kinuya, Kenichi Harada, Tetsuo Ohta, Wataru Koda, Osamu Matsui, Toshifumi Gabata. Differences in 18F-FDG Uptake and Expression of Glucose Transporter Between 2 Distinct Subtypes of Mass-Forming Intrahepatic CholangiocarcinomasClinical Nuclear Medicine 2020; 45(6): e267 doi: 10.1097/RLU.0000000000003055
4
YouJin Lee, DongWook Choi, Sunjong Han, In Woong Han, Jin Seok Heo, Seong Ho Choi. Comparison analysis of left-side versus right-side resection in bismuth type III hilar cholangiocarcinomaAnnals of Hepato-Biliary-Pancreatic Surgery 2018; 22(4): 350 doi: 10.14701/ahbps.2018.22.4.350
5
Dominic Ku, Reuben Tang, Tony Pang, Henry Pleass, Arthur Richardson, Lawrence Yuen, Vincent Lam. Survival outcomes of hepatic resections in Bismuth‐Corlette type IV cholangiocarcinomaANZ Journal of Surgery 2020; 90(9): 1604 doi: 10.1111/ans.15531
6
Zeki Akca, Hasan Mutlu, Abdulsamet Erden, Abdullah Buyukcelik, Yasemin Benderli Cihan, Sema Sezgin Goksu, Tuncay Aslan, Emel Yaman Sezer, Ali Inal. Survival Analysis of Biliary Tract Cancer Cases in TurkeyAsian Pacific Journal of Cancer Prevention 2014; 15(15): 6025 doi: 10.7314/APJCP.2014.15.15.6025
7
Trevor A. Flood, Dhanpat Jain, E. Celia Marginean. Malignant tumours of gallbladder and extrahepatic bile ductsDiagnostic Histopathology 2010; 16(8): 360 doi: 10.1016/j.mpdhp.2010.06.003
8
Lunan Yan, Yan Zhong. Operative Techniques in Liver Resection2016; : 191 doi: 10.1007/978-94-017-7411-6_21
9
Ke Ma, Xin Wei, Danfeng Dong, Yinying Wu, Qianqian Geng, Enxiao Li. PD-L1 and PD-1 expression correlate with prognosis in extrahepatic cholangiocarcinomaOncology Letters 2017; 14(1): 250 doi: 10.3892/ol.2017.6105
10
Junji Furuse, Takuji Okusaka. Targeted Therapy for Biliary Tract CancerCancers 2011; 3(2): 2243 doi: 10.3390/cancers3022243
11
G.-Q. Zhu, K.-Q. Shi, J. You, H. Zou, Y.-Q. Lin, L.-R. Wang, M. Braddock, Y.-P. Chen, M.-H. Zheng. Systematic review with network meta-analysis: adjuvant therapy for resected biliary tract cancerAlimentary Pharmacology & Therapeutics 2014; 40(7): 759 doi: 10.1111/apt.12900
12
Byung Ihn Choi. Diseases of the Abdomen and Pelvis 2014–20172014; : 111 doi: 10.1007/978-88-470-5659-6_13
13
Domenico Alvaro, Renato Cannizzaro, Roberto Labianca, Francesca Valvo, Fabio Farinati. Cholangiocarcinoma: A position paper by the Italian Society of Gastroenterology (SIGE), the Italian Association of Hospital Gastroenterology (AIGO), the Italian Association of Medical Oncology (AIOM) and the Italian Association of Oncological Radiotherapy (AIRO)Digestive and Liver Disease 2010; 42(12): 831 doi: 10.1016/j.dld.2010.06.005
14
学河 朱. Typing, Risk Factors and Related Treatments of CholangiocarcinomaAdvances in Clinical Medicine 2014; 4(04): 74 doi: 10.12677/ACM.2014.44014
15
T. Peter Kingham, Victoria G. Aveson, Alice C. Wei, Jason A. Castellanos, Peter J. Allen, Daniel P. Nussbaum, Yinin Hu, Michael I. D'Angelica. Surgical management of biliary malignancyCurrent Problems in Surgery 2021; 58(2): 100854 doi: 10.1016/j.cpsurg.2020.100854
16
X. Y. Yin. Hilar Cholangiocarcinoma2013; : 91 doi: 10.1007/978-94-007-6473-6_8
17
Marc Pracht, Guillaume Le Roux, Laurent Sulpice, Habiba Mesbah, Sylvain Manfredi, Odile Audrain, Karim Boudjema, Jean-Luc Raoul, Eveline Boucher. Chemotherapy for Inoperable Advanced or Metastatic Cholangiocarcinoma: Retrospective Analysis of 78 Cases in a Single Center over Four YearsChemotherapy 2012; 58(2): 134 doi: 10.1159/000337289
18
Bingyan Liu, Shuo Yan, Yiping Jia, Jun Ma, Shaoqiu Wu, Yuyao Xu, Mingyi Shang, Aiwu Mao. TLR2 promotes human intrahepatic cholangiocarcinoma cell migration and invasion by modulating NF-κB pathway-mediated inflammatory responsesThe FEBS Journal 2016; 283(20): 3839 doi: 10.1111/febs.13894
19
Massimiliano Cadamuro, Tommaso Stecca, Simone Brivio, Valeria Mariotti, Romina Fiorotto, Carlo Spirli, Mario Strazzabosco, Luca Fabris. The deleterious interplay between tumor epithelia and stroma in cholangiocarcinomaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1435 doi: 10.1016/j.bbadis.2017.07.028
20
Manida Suksawat, Poramate Klanrit, Jutarop Phetcharaburanin, Nisana Namwat, Narong Khuntikeo, Attapol Titapun, Apiwat Jarearnrat, Prakasit Sa-ngiamwibool, Anchalee Techasen, Watcharin Loilome, Gianfranco D. Alpini. In vitro and molecular chemosensitivity in human cholangiocarcinoma tissuesPLOS ONE 2019; 14(9): e0222140 doi: 10.1371/journal.pone.0222140
21
Bradley N. Reames, Timothy M. Pawlik. Surgical Diseases of the Pancreas and Biliary Tree2018; : 345 doi: 10.1007/978-981-10-8755-4_14
22
F. Bibeau, N. Guedj. Tumeurs des voies biliaires: difficultés et pièges diagnostiques en anatomie pathologiqueOncologie 2012; 14(3): 133 doi: 10.1007/s10269-012-2136-y
23
Gui-Li Huang, Qi Luo, Gang Rui, Wei Zhang, Qiu-Yan Zhang, Qing-Xi Chen, Dong-Yan Shen. Oncogenic Activity of Retinoic Acid Receptor γ Is Exhibited through Activation of the Akt/NF-κB and Wnt/β-Catenin Pathways in CholangiocarcinomaMolecular and Cellular Biology 2013; 33(17): 3416 doi: 10.1128/MCB.00384-13
24
Mingwu Li, Ming Bai, Xingshun Qi, Kai Li, Zhanxin Yin, Jianhong Wang, Wenbing Wu, Luanluan Zhen, Chuangye He, Daiming Fan, Zhuoli Zhang, Guohong Han. Percutaneous Transhepatic Biliary Metal Stent for Malignant Hilar Obstruction: Results and Predictive Factors for Efficacy in 159 Patients from a Single CenterCardioVascular and Interventional Radiology 2015; 38(3): 709 doi: 10.1007/s00270-014-0992-0
25
J. Y. H. Chan, K. K. H. Lee, Y. L. Chui. Hilar Cholangiocarcinoma2013; : 111 doi: 10.1007/978-94-007-6473-6_10
26
Hanisah Guro, Jin Won Kim, YoungRok Choi, Jai Young Cho, Yoo-Seok Yoon, Ho-Seong Han. Multidisciplinary management of intrahepatic cholangiocarcinoma: Current approachesSurgical Oncology 2017; 26(2): 146 doi: 10.1016/j.suronc.2017.03.001
27
X-F Liu, H Jiang, C-S Zhang, S-P Yu, Z-Q Wang, H-L Su. Targeted Drug Regulation on Methylation of p53—BAX Mitochondrial Apoptosis Pathway Affects the Growth of Cholangiocarcinoma CellsJournal of International Medical Research 2012; 40(1): 67 doi: 10.1177/147323001204000107
28
Ana Filipa Brito, Marina Ribeiro, Ana Margarida Abrantes, Ana Catarina Mamede, Mafalda Laranjo, João Eduardo Casalta-Lopes, Ana Cristina Gonçalves, Ana Bela Sarmento-Ribeiro, José Guilherme Tralhão, Maria Filomena Botelho. New Approach for Treatment of Primary Liver Tumors: The Role of QuercetinNutrition and Cancer 2016; 68(2): 250 doi: 10.1080/01635581.2016.1145245
29
Tobias Kiesslich, Daniel Neureiter, Gernot W Wolkersdörfer, Kristjan Plaetzer, Frieder Berr. Advances in photodynamic therapy for the treatment of hilar biliary tract cancerFuture Oncology 2010; 6(12): 1925 doi: 10.2217/fon.10.147
30
Marianne Sinn, Sven Bischoff, Oliver Nehls, Uwe Pelzer, Fritz von Weizsäcker, Stefan Kubicka, Jens M. Stieler, Karel Caca, Hanno Riess. Biliary Tract Cancer: A Survey Regarding the Current Oncological Daily Care Practice in GermanyOnkologie 2012; 35(12): 755 doi: 10.1159/000345115
31
Sarah B. Fisher, Sameer H. Patel, David A. Kooby, Sharon Weber, Mark Bloomston, Clifford Cho, Ioannis Hatzaras, Carl Schmidt, Emily Winslow, Charles A. Staley, Shishir K. Maithel. Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysisHPB 2012; 14(8): 514 doi: 10.1111/j.1477-2574.2012.00489.x
32
Qihong Ni, Haolu Wang, Yunhe Zhang, Lijun Qian, Jiachang Chi, Xiaowen Liang, Tao Chen, Jian Wang. MDCT assessment of resectability in hilar cholangiocarcinomaAbdominal Radiology 2017; 42(3): 851 doi: 10.1007/s00261-016-0943-0
33
Kosin Wirasorn, Thundon Ngamprasertchai, Narong Khuntikeo, Ake Pakkhem, Piti Ungarereevittaya, Jarin Chindaprasirt, Aumkhae Sookprasert. Adjuvant chemotherapy in resectable cholangiocarcinoma patientsJournal of Gastroenterology and Hepatology 2013; 28(12): 1885 doi: 10.1111/jgh.12321
34
Bundit Promraksa, Praewpan Katrun, Jutarop Phetcharaburanin, Yingpinyapat Kittirat, Nisana Namwat, Anchalee Techasen, Jia V. Li, Watcharin Loilome. Metabolic Changes of Cholangiocarcinoma Cells in Response to Coniferyl Alcohol TreatmentBiomolecules 2021; 11(3): 476 doi: 10.3390/biom11030476
35
Z. Y. Huang, X. P. Chen. Hilar Cholangiocarcinoma2013; : 211 doi: 10.1007/978-94-007-6473-6_19
36
H. Petrowsky, J.C. Hong. Current Surgical Management of Hilar and Intrahepatic Cholangiocarcinoma: The Role of Resection and Orthotopic Liver TransplantationTransplantation Proceedings 2009; 41(10): 4023 doi: 10.1016/j.transproceed.2009.11.001
37
B. I. Choi, J. M. Lee. Hilar Cholangiocarcinoma2013; : 53 doi: 10.1007/978-94-007-6473-6_5
38
Zhi-Hua Li, Qi-Bin Tang, Jie Wang, Ling Zhou, Wen-lin Huang, Ran-Yi Liu, Ru-Fu Chen. Hepatitis C virus core protein induces malignant transformation of biliary epithelial cells by activating nuclear factor-κB pathwayJournal of Gastroenterology and Hepatology 2010; 25(7): 1315 doi: 10.1111/j.1440-1746.2009.06201.x
39
Angela Lamarca, Julien Edeline, Mairéad G McNamara, Richard A Hubner, Masato Nagino, John Bridgewater, John Primrose, Juan W Valle. Current standards and future perspectives in adjuvant treatment for biliary tract cancersCancer Treatment Reviews 2020; 84: 101936 doi: 10.1016/j.ctrv.2019.101936
40
John G. Phillips, John A. Wolfgang, Theodore S. Hong. Biliary Tract and Gallbladder CancerMedical Radiology 2014; : 311 doi: 10.1007/978-3-642-40558-7_21
41
Yu Akazawa, Shoichi Mizuno, Norihiro Fujinami, Toshihiro Suzuki, Yusuke Yoshioka, Takahiro Ochiya, Yasunari Nakamoto, Tetsuya Nakatsura. Usefulness of serum microRNA as a predictive marker of recurrence and prognosis in biliary tract cancer after radical surgeryScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-42392-7
42
Junichi Shindoh, Giuseppe Zimmitti, Jean-Nicolas Vauthey. Biliary Tract and Gallbladder CancerMedical Radiology 2014; : 253 doi: 10.1007/978-3-642-40558-7_16
43
M. Grunnet, M. Mau-Sørensen. Serum tumor markers in bile duct cancer – a reviewBiomarkers 2014; 19(6): 437 doi: 10.3109/1354750X.2014.923048
44
Jin Hyoung Kim, Hyung Jin Won, Yong Moon Shin, Kyung-Ah Kim, Pyo Nyun Kim. Radiofrequency Ablation for the Treatment of Primary Intrahepatic CholangiocarcinomaAmerican Journal of Roentgenology 2011; 196(2): W205 doi: 10.2214/AJR.10.4937
45
Zhenzhen Liang, Xin Liu, Qian Zhang, Chunpeng Wang, Yinlong Zhao. Diagnostic value of microRNAs as biomarkers for cholangiocarcinomaDigestive and Liver Disease 2016; 48(10): 1227 doi: 10.1016/j.dld.2016.07.006
46
Anusha Kalbasi, Edgar Ben-Josef. Radiation Therapy for Gastrointestinal Cancers2017; : 131 doi: 10.1007/978-3-319-43115-4_11
47
Min-hang Zhou, Hong-wei Zhou, Mo Liu, Jun-zhong Sun. The role of miR-92b in cholangiocarcinoma patientsThe International Journal of Biological Markers 2018; 33(3): 293 doi: 10.1177/1724600817751524
48
Yongjun Chen, Jian Luo, Rui Tian, Huawen Sun, Shengquan Zou. miR-373 Negatively Regulates Methyl-CpG-Binding Domain Protein 2 (MBD2) in Hilar CholangiocarcinomaDigestive Diseases and Sciences 2011; 56(6): 1693 doi: 10.1007/s10620-010-1481-1
49
S.-Y. Park, J.H. Kim, H.-J. Yoon, I.-S. Lee, H.-K. Yoon, K.-P. Kim. Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinomaClinical Radiology 2011; 66(4): 322 doi: 10.1016/j.crad.2010.11.002
50
Yu Wang, Wei Cui, Wenzhe Fan, Yingqiang Zhang, Wang Yao, Kunbo Huang, Jiaping Li. Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinomaOncotarget 2016; 7(33): 53911 doi: 10.18632/oncotarget.10116
51
Min-Hua Chen, Po-Chin Liang, Kai-Chun Chang, Jian-Yuan Huang, Yu-Ting Chang, Fuh-Yu Chang, Jau-Min Wong, Feng-Huei Lin. Prototype of biliary drug-eluting stent with photodynamic and chemotherapy using electrospinningBioMedical Engineering OnLine 2014; 13(1) doi: 10.1186/1475-925X-13-118
52
Liu Xiaofang, Tang Kun, Yu Shaoping, Wang Zaiqiu, Su Hailong. Correlation between promoter methylation of p14 ARF , TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinomaWorld Journal of Surgical Oncology 2012; 10(1) doi: 10.1186/1477-7819-10-5
53
A Höblinger, T Gerhardt, MA González-Carmona, R Hüneburg, T Sauerbruch, V Schmitz. Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinomaEuropean Journal of Medical Research 2011; 16(9): 391 doi: 10.1186/2047-783X-16-9-391
54
Alessandra Gentilini, Mirella Pastore, Fabio Marra, Chiara Raggi. The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor EpitheliumInternational Journal of Molecular Sciences 2018; 19(10): 2885 doi: 10.3390/ijms19102885
55
F. Rauchfuss, H. Scheuerlein, M. Götz, Y. Dittmar, R. Voigt, M. Heise, U. Settmacher. Hepatozelluläres Karzinom und CholangiokarzinomDer Chirurg 2010; 81(10): 941 doi: 10.1007/s00104-009-1864-z
56
Hongwei Sun, Ying Li, Hongru Kong, Shengjie Dai, Haixin Qian. Dysregulation of KCNQ1OT1 promotes cholangiocarcinoma progression via miR-140-5p/SOX4 axisArchives of Biochemistry and Biophysics 2018; 658: 7 doi: 10.1016/j.abb.2018.09.019
57
Giada Rossignoli, Alessandro Grottesi, Giovanni Bisello, Riccardo Montioli, Carla Borri Voltattorni, Alessandro Paiardini, Mariarita Bertoldi. Cysteine 180 Is a Redox Sensor Modulating the Activity of Human Pyridoxal 5′-Phosphate Histidine DecarboxylaseBiochemistry 2018; 57(44): 6336 doi: 10.1021/acs.biochem.8b00625
58
Jin Hyoung Kim, Hyung Jin Won, Yong Moon Shin, Pyo Nyun Kim, Sung-Gyu Lee, Shin Hwang. Radiofrequency ablation for recurrent intrahepatic cholangiocarcinoma after curative resectionEuropean Journal of Radiology 2011; 80(3): e221 doi: 10.1016/j.ejrad.2010.09.019
59
Michael G. House, Keith D. Lillemoe. Handbook of Liver Disease2018; : 499 doi: 10.1016/B978-0-323-47874-8.00036-5
60
Anna Melissa Schlitter, Irene Esposito. Definition of Microscopic Tumor Clearance (R0) in Pancreatic Cancer ResectionsCancers 2010; 2(4): 2001 doi: 10.3390/cancers2042001
61
MARCO MASSANI, TOMMASO STECCA, LUCA FABRIS, EZIO CARATOZZOLO, CESARE RUFFOLO, ALBERTO FURLANETTO, STUART MORTON, MASSIMILIANO CADAMURO, MARIO STRAZZABOSCO, NICOLÒ BASSI. Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: A novel in vitro model to study tumor-stroma interactionsOncology Reports 2013; 30(3): 1143 doi: 10.3892/or.2013.2568
62
N. S. Skreptsova, S. O. Stepanov, L. A. Mitina, A. D. Kaprin, A. A. Kostin, A. N. Vostrov, D. V. Dolgacheva, N. V. Evtyagina. Modern ultrasound diagnosis of cholangiocarcinoma (Klatskin's tumor)Onkologiya. Zhurnal imeni P.A.Gertsena 2018; 7(4): 38 doi: 10.17116/onkolog20187438
63
Ying Wang, Nayiyuan Wu, Xia Luo, Xiaoyun Zhang, Qianjin Liao, Jing Wang. SOX2OT, a novel tumor-related long non-coding RNABiomedicine & Pharmacotherapy 2020; 123: 109725 doi: 10.1016/j.biopha.2019.109725
64
Somsak Likhitrattanapisal, Supeecha Kumkate, Pravech Ajawatanawong, Kanokpan Wongprasert, Rutaiwan Tohtong, Tavan Janvilisri. Dysregulation of microRNA in cholangiocarcinoma identified through a meta-analysis of microRNA profilingWorld Journal of Gastroenterology 2020; 26(29): 4356-4371 doi: 10.3748/wjg.v26.i29.4356
65
Francesco Antonio Polistina, Rosabianca Guglielmi, Cristina Baiocchi, Paolo Francescon, Paolo Scalchi, Antonio Febbraro, Giorgio Costantin, Giovanni Ambrosino. Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experienceRadiotherapy and Oncology 2011; 99(2): 120 doi: 10.1016/j.radonc.2011.05.016
66
Yoko Yashima, Shinpei Sato, Toshihiro Kawai, Takafumi Sugimoto, Takahisa Sato, Miho Kanda, Shuntaro Obi. Intraarterial 5-fluorouracil and interferon therapy is safe and effective for nonresectable biliary tract adenocarcinomaHepatology International 2015; 9(1): 142 doi: 10.1007/s12072-014-9583-z
67
Yongjia Yan, Ning Lu, Weijun Tian, Tong Liu. Evolution of Surgery for Klatskin Tumor Demonstrates Improved Outcome: A Single Center AnalysisTumori Journal 2014; 100(6): e250 doi: 10.1177/1778.19288
68
Gianluca Rompianesi, Marcello Di Martino, Alex Gordon-Weeks, Roberto Montalti, Roberto Troisi. Liquid biopsy in cholangiocarcinoma: Current status and future perspectivesWorld Journal of Gastrointestinal Oncology 2021; 13(5): 332-350 doi: 10.4251/wjgo.v13.i5.332
69
Lea Matsuoka, Sophoclis Alexopoulos, Lydia Petrovik, Linda Chan, Yuri Genyk, Rick Selby. Trisectionectomy for Cholangiocarcinoma: Is it Worth It?The American Surgeon 2014; 80(6): 544 doi: 10.1177/000313481408000616
70
Kritiya Butthongkomvong, Ekaphop Sirachainan, Supattra Jhankumpha, Surang Kumdang, On-Usa Sukhontharot. Treatment Outcome of Palliative Chemotherapy in Inoperable Cholangiocarcinoma in ThailandAsian Pacific Journal of Cancer Prevention 2013; 14(6): 3565 doi: 10.7314/APJCP.2013.14.6.3565
71
Shin Hamada, Kennichi Satoh, Morihisa Hirota, Atsushi Kanno, Kazuyuki Ishida, Jun Umino, Hiromichi Ito, Kazuhiro Kikuta, Kiyoshi Kume, Atsushi Masamune, Yu Katayose, Michiaki Unno, Tooru Shimosegawa. Calcium-binding protein S100P is a novel diagnostic marker of cholangiocarcinomaCancer Science 2011; 102(1): 150 doi: 10.1111/j.1349-7006.2010.01757.x
72
L. Zender, N. P. Malek. Diagnostik und Therapie des cholangiozellulären KarzinomsDer Internist 2016; 57(12): 1191 doi: 10.1007/s00108-016-0128-5
73
Vijayadershan Muppidi, Sreenath Meegada, James D Eaton, Satheesh P Nair, Rajanshu Verma. Recurrent Cholangiocarcinoma Presenting as Sister Mary Joseph Nodule After Liver TransplantationCureus 2020;  doi: 10.7759/cureus.11673
74
Wen-long Yu, Wen-ming Cong, Yongjie Zhang, Ying Chen, Fei Wang, Guanzhen Yu. Overexpression of ATA1/SLC38A1 Predicts Future Recurrence and Death in Chinese Patients with Hilar CholangiocarcinomaJournal of Surgical Research 2011; 171(2): 663 doi: 10.1016/j.jss.2010.03.049
75
Feng Feng, Xuehui Cao, Xueqing Liu, Jianzhang Qin, Shubin Zhang, Qiusheng Li, Jianhua Liu. Laparoscopic resection for Bismuth type III and IV hilar cholangiocarcinoma: How to improve the radicality without direct palpationJournal of Surgical Oncology 2019; 120(8): 1379 doi: 10.1002/jso.25739
76
N. Ispikoudis, F. Rauchfuss, R. Voigt, H. Scheuerlein, E. Bärthel, Y. Dittmar, U. Settmacher. Chirurgische Therapie von primären Lebertumoren bei ErwachsenenDer Onkologe 2012; 18(7): 617 doi: 10.1007/s00761-012-2245-7
77
D.P.S. Sohal, K. Mykulowycz, T. Uehara, U.R. Teitelbaum, N. Damjanov, B.J. Giantonio, M. Carberry, P. Wissel, M. Jacobs-Small, P.J. O'Dwyer, A. Sepulveda, W. Sun. A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinomaAnnals of Oncology 2013; 24(12): 3061 doi: 10.1093/annonc/mdt416
78
Cemal Yazici, David J Niemeyer, David A Iannitti, Mark W Russo. Hepatocellular carcinoma and cholangiocarcinoma: an updateExpert Review of Gastroenterology & Hepatology 2014; 8(1): 63 doi: 10.1586/17474124.2014.852468
79
Steven Reitz, Kristine Slam, Lowell W. Chambers. Biliary, Pancreatic, and Hepatic Imaging for the General SurgeonSurgical Clinics of North America 2011; 91(1): 59 doi: 10.1016/j.suc.2010.10.005
80
Valeriy V. Boyko, Yuriy V. Avdosyev, Anastasiia L. Sochnieva, Denys O. Yevtushenko, Dmitro V. Minukhin. PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY IN THE DIAGNOSTICS OF COMMON BILE DUCT DISEASES COMPLICATED BY OBSTRUCTIVE JAUNDICE*Emergency Medical Service 2021; 8(2): 62 doi: 10.36740/EmeMS202102102
81
Steven P. O’Hara, Sergio A. Gradilone, Tetyana V. Masyuk, James H. Tabibian, Nicholas F. LaRusso. MicroRNAs in CholangiopathiesCurrent Pathobiology Reports 2014; 2(3): 133 doi: 10.1007/s40139-014-0048-9
82
L. Chiche, B. Menahem, L. Plard. Tumeurs kystiques et non kystiques biliairesEMC - Traité de médecine AKOS 2013; 8(1): 1 doi: 10.1016/S1634-6939(12)54655-7
83
Qiang Huang, Lei Liu, Chen-Hai Liu, Feng Shao, Fang Xie, Chuan-Hai Zhang, San-Yuan Hu. Expression of Smad7 in Cholangiocarcinoma: Prognostic Significance and Implications for Tumor MetastasisAsian Pacific Journal of Cancer Prevention 2012; 13(10): 5161 doi: 10.7314/APJCP.2012.13.10.5161
84
Constantin A Dasanu, Shounak Majumder, Guru Trikudanathan. Emerging pharmacotherapeutic strategies for cholangiocarcinomaExpert Opinion on Pharmacotherapy 2011; 12(12): 1865 doi: 10.1517/14656566.2011.583919
85
Kun Cao, Bo Li, Ye-Wei Zhang, Hui Song, Yi-Gang Chen, Yong-Jun Gong, Hai-Yang Li, Shi Zuo. miR-29b restrains cholangiocarcinoma progression by relieving DNMT3B-mediated repression of CDKN2B expressionAging 2021; 13(4): 6055 doi: 10.18632/aging.202549
86
Andrew M. Gaya. Stereotactic Body Radiotherapy2015; : 149 doi: 10.1007/978-0-85729-597-2_9
87
Yi Xu, Yue Yao, Kaiming Leng, Zhenglong Li, Wei Qin, Xiangyu Zhong, Pengcheng Kang, Ming Wan, Xingming Jiang, Yunfu Cui. Long non-coding RNA UCA1 indicates an unfavorable prognosis and promotes tumorigenesis via regulating AKT/GSK-3β signaling pathway in cholangiocarcinomaOncotarget 2017; 8(56): 96203 doi: 10.18632/oncotarget.21884
88
Yi Xu, Yue Yao, Xingming Jiang, Xiangyu Zhong, Zhidong Wang, Chunlong Li, Pengcheng Kang, Kaiming Leng, Daolin Ji, Zhenglong Li, Lining Huang, Wei Qin, Yunfu Cui. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinomaJournal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0747-x
89
Junji Furuse, Takuji Okusaka, John Bridgewater, Masanori Taketsuna, Harpreet Wasan, Minori Koshiji, Juan Valle. Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancerCritical Reviews in Oncology/Hematology 2011; 80(1): 31 doi: 10.1016/j.critrevonc.2010.10.009
90
Brendan Boland, Amanda Kim, Nicholas Nissen, Steve Colquhoun. Cholangiocarcinoma: Aggressive Surgical Intervention Remains JustifiedThe American Surgeon 2012; 78(2): 157 doi: 10.1177/000313481207800231
91
Michela Squadroni, Luca Tondulli, Gemma Gatta, Stefania Mosconi, Giordano Beretta, Roberto Labianca. CholangiocarcinomaCritical Reviews in Oncology/Hematology 2017; 116: 11 doi: 10.1016/j.critrevonc.2016.11.012
92
B. K. P. Goh, C. B. Rosen. Hilar Cholangiocarcinoma2013; : 281 doi: 10.1007/978-94-007-6473-6_26
93
Yang Yu, Yan Chen, Jianxia Ma, Xiaofeng Yu, Guanzhen Yu, Zhaoshen Li. SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinomaTumor Biology 2016; 37(3): 4159 doi: 10.1007/s13277-015-4206-4
94
Yohei Ota, Ryusei Matsuyama, Koichi Taniguchi, Michio Ueda, Kazuhisa Takeda, Kuniya Tanaka, Takashi Nakayama, Itaru Endo. Solitary rib recurrence of hilar cholangiocarcinoma 10 years after resection: report of a caseClinical Journal of Gastroenterology 2013; 6(6): 485 doi: 10.1007/s12328-013-0432-8
95
Gun Ha Kim, Pyeong Hwa Kim, Jin Hyoung Kim, Pyo-Nyun Kim, Hyung Jin Won, Yong Moon Shin, Sang Hyun Choi. Thermal ablation in the treatment of intrahepatic cholangiocarcinoma: a systematic review and meta-analysisEuropean Radiology 2021;  doi: 10.1007/s00330-021-08216-x
96
Matthew Cwinn, Gordon Walsh, Sheikh Hasibur Rahman, Michele Molinari. The Geography of Primary Hepatic Neoplasms Treatments in Canada: Changes in Latitudes and Changes in AttitudesCanadian Journal of Gastroenterology and Hepatology 2017; 2017: 1 doi: 10.1155/2017/9365657
97
L. Chiche, B. Menahem, L. Plard. Tumori cistici e non cistici biliariEMC - AKOS - Trattato di Medicina 2013; 15(2): 1 doi: 10.1016/S1634-7358(13)64592-1
98
Jan B. Kuhlmann, Wulf Euringer, Hans C. Spangenberg, Matthias Breidert, Hubert E. Blum, Jan Harder, Richard Fischer. Treatment of unresectable cholangiocarcinomaEuropean Journal of Gastroenterology & Hepatology 2012; : 1 doi: 10.1097/MEG.0b013e3283502241
99
Reiji Sugita. Magnetic resonance evaluations of biliary malignancy and condition at high-risk for biliary malignancy: Current statusWorld Journal of Hepatology 2013; 5(12): 654-665 doi: 10.4254/wjh.v5.i12.654
100
Divyesh Sejpal. Advancements in Biliary StentingJournal of Clinical Gastroenterology 2012; 46(3): 191 doi: 10.1097/MCG.0b013e3182410367
101
Dimitris Zacharoulis, Olga Lazoura, Eleni Sioka, Spyros Potamianos, George Tzovaras, Joanna Nicholls, George Koukoulis, Nagy Habib. Habib EndoHPB: A Novel Endobiliary Radiofrequency Ablation Device. An Experimental StudyJournal of Investigative Surgery 2013; 26(1): 6 doi: 10.3109/08941939.2012.681832
102
Michelle A. Anderson, Vasu Appalaneni, Tamir Ben-Menachem, G. Anton Decker, Dayna S. Early, John A. Evans, Robert D. Fanelli, Deborah A. Fisher, Laurel R. Fisher, Norio Fukami, Joo Ha Hwang, Steven O. Ikenberry, Rajeev Jain, Terry L. Jue, Khalid Khan, Mary Lee Krinsky, Phyllis M. Malpas, John T. Maple, Ravi N. Sharaf, Amandeep K. Shergill, Jason A. Dominitz, Brooks D. Cash. The role of endoscopy in the evaluation and treatment of patients with biliary neoplasiaGastrointestinal Endoscopy 2013; 77(2): 167 doi: 10.1016/j.gie.2012.09.029
103
Jens Sperling, Christoph Justinger, Jochen Schuld, Christian Ziemann, Roland Seidel, Otto Kollmar. Intrahepatic cholangiocarcinoma in a transplant liver - selective internal radiation therapy followed by right hemihepatectomy: report of a caseWorld Journal of Surgical Oncology 2014; 12(1) doi: 10.1186/1477-7819-12-198
104
Phonepasong Ayé Soukhathammavong, Youthanavanh Vonghachack, Christoph Hatz, Kongsap Akkhavong, Peter Odermatt. Suspected cases of cholangiocarcinoma seen in reference hospitals in Lao People's Democratic RepublicParasitology International 2017; 66(4): 510 doi: 10.1016/j.parint.2016.11.011
105
Sun Choon Song, Dong Wook Choi, Alfred Wei-Chieh Kow, Seong Ho Choi, Jin Seok Heo, Woo Seok Kim, Min Jung Kim. Surgical outcomes of 230 resected hilar cholangiocarcinoma in a single centreANZ Journal of Surgery 2013; 83(4): 268 doi: 10.1111/j.1445-2197.2012.06195.x
106
Monika Vyas, Dhanpat Jain. A practical diagnostic approach to hepatic massesIndian Journal of Pathology and Microbiology 2018; 61(1): 2 doi: 10.4103/IJPM.IJPM_578_17
107
Marco Massani, Tommaso Stecca, Bruno Pauletti, Gianpaolo Marte, Cesare Ruffolo, Luca Bonariol, Nicolo’ Bassi. Topics in the Surgery of the Biliary Tree2018;  doi: 10.5772/intechopen.75516
108
Sarah JL Payne, Justin Stebbing, Peter Wilson, Sarah Slater. Outcomes in unresectable and locally advanced resected cholangiocarcinomaExpert Review of Anticancer Therapy 2011; 11(5): 705 doi: 10.1586/era.11.32
109
Nipaporn Ngernyuang, Wunchana Seubwai, Sakda Daduang, Patcharee Boonsiri, Temduang Limpaiboon, Jureerut Daduang. Targeted delivery of 5-fluorouracil to cholangiocarcinoma cells using folic acid as a targeting agentMaterials Science and Engineering: C 2016; 60: 411 doi: 10.1016/j.msec.2015.11.062
110
Jan Grendar, Petra Grendarova, Richie Sinha, Elijah Dixon. Neoadjuvant therapy for downstaging of locally advanced hilar cholangiocarcinoma: a systematic reviewHPB 2014; 16(4): 297 doi: 10.1111/hpb.12150
111
Jinyang Gu, Jianling Bai, Xiaolei Shi, Jianxin Zhou, Yudong Qiu, Yafu Wu, Chunping Jiang, Xitai Sun, Fanggui Xu, Yue Zhang, Yitao Ding. Efficacy and safety of liver transplantation in patients with cholangiocarcinoma: A systematic review and meta-analysisInternational Journal of Cancer 2012; 130(9): 2155 doi: 10.1002/ijc.26019
112
Jonas Högberg, Magnus Rizell, Ragnar Hultborn, Johanna Svensson, Olof Henrikson, Johan Mölne, Peter Gjertsson, Peter Bernhardt. Heterogeneity of microsphere distribution in resected liver and tumour tissue following selective intrahepatic radiotherapyEJNMMI Research 2014; 4(1) doi: 10.1186/s13550-014-0048-0
113
Mehdi Mohamadnejad, John M. DeWitt, Stuart Sherman, Julia K. LeBlanc, Henry A. Pitt, Michael G. House, Kelly J. Jones, Evan L. Fogel, Lee McHenry, James L. Watkins, Gregory A. Cote, Glen A. Lehman, Mohammad A. Al-Haddad. Role of EUS for preoperative evaluation of cholangiocarcinoma: a large single-center experienceGastrointestinal Endoscopy 2011; 73(1): 71 doi: 10.1016/j.gie.2010.08.050
114
Jesper B. Andersen, Bart Spee, Boris R. Blechacz, Itzhak Avital, Mina Komuta, Andrew Barbour, Elizabeth A. Conner, Matthew C. Gillen, Tania Roskams, Lewis R. Roberts, Valentina M. Factor, Snorri S. Thorgeirsson. Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase InhibitorsGastroenterology 2012; 142(4): 1021 doi: 10.1053/j.gastro.2011.12.005
115
Suzanne C. Schiffman, Tiffany Metzger, Gregory Dubel, Tomas Andrasina, Ivan Kralj, Cliff Tatum, Kelly M. McMasters, Charles R. Scoggins, Robert C. G. Martin. Precision Hepatic Arterial Irinotecan Therapy in the Treatment of Unresectable Intrahepatic Cholangiocellular Carcinoma: Optimal Tolerance and Prolonged Overall SurvivalAnnals of Surgical Oncology 2011; 18(2): 431 doi: 10.1245/s10434-010-1333-4
116
Kichang Han, Heung Kyu Ko, Kyung Won Kim, Hyung Jin Won, Yong Moon Shin, Pyo Nyun Kim. Radiofrequency Ablation in the Treatment of Unresectable Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-AnalysisJournal of Vascular and Interventional Radiology 2015; 26(7): 943 doi: 10.1016/j.jvir.2015.02.024
117
Scott R. Gerst, Richard Kinh Gian Do. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set2017; : 358 doi: 10.1016/B978-0-323-34062-5.00019-4
118
Antonello A. Romani, Silvia Desenzani, Marina M. Morganti, Maria Cristina Baroni, Angelo F. Borghetti, Paolo Soliani. The BH3-mimetic ABT-737 targets the apoptotic machinery in cholangiocarcinoma cell lines resulting in synergistic interactions with zoledronic acidCancer Chemotherapy and Pharmacology 2011; 67(3): 557 doi: 10.1007/s00280-010-1345-6
119
Arjun Nanda, Jason M. Brown, Stephen H. Berger, Melinda M. Lewis, Emily G. Barr Fritcher, Gregory J. Gores, Steven A. Keilin, Kevin E. Woods, Qiang Cai, Field F. Willingham. Triple modality testing by endoscopic retrograde cholangiopancreatography for the diagnosis of cholangiocarcinomaTherapeutic Advances in Gastroenterology 2015; 8(2): 56 doi: 10.1177/1756283X14564674
120
Huihong Liang, Zhenwei Peng, Liangqi Cao, Shikun Qian, Zili Shao. Metal Stenting with or without Endobiliary Radiofrequency Ablation for Unresectable Extrahepatic CholangiocarcinomaJournal of Cancer Therapy 2015; 6(11): 981 doi: 10.4236/jct.2015.611106
121
Michiyo Higashi, Norishige Yamada, Seiya Yokoyama, Sho Kitamoto, Kazuhiro Tabata, Chihaya Koriyama, Surinder K. Batra, Suguru Yonezawa. Pathobiological Implications of MUC16/CA125 Expression in Intrahepatic Cholangiocarcinoma-Mass Forming TypePathobiology 2012; 79(2): 101 doi: 10.1159/000335164
122
Benjamin L. Yam, Evan S. Siegelman. MR Imaging of the Biliary SystemRadiologic Clinics of North America 2014; 52(4): 725 doi: 10.1016/j.rcl.2014.02.011
123
Amy L. Collins, Sylwia Wojcik, James Liu, Wendy L. Frankel, Hansjuerg Alder, Lianbo Yu, Thomas D. Schmittgen, Carlo M. Croce, Mark Bloomston. A Differential MicroRNA Profile Distinguishes Cholangiocarcinoma from Pancreatic AdenocarcinomaAnnals of Surgical Oncology 2014; 21(1): 133 doi: 10.1245/s10434-013-3240-y
124
Matthew V. Kiefer, Marissa Albert, Madeline McNally, Mary Robertson, Weijing Sun, Douglas Fraker, Kim Olthoff, Kathleen Christians, Sam Pappas, William Rilling, Michael C. Soulen. Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcoholCancer 2011; 117(7): 1498 doi: 10.1002/cncr.25625
125
Kai Qu, Si-Nan Liu, Hu-Lin Chang, Chang Liu, Xin-Sen Xu, Rui-Tao Wang, Lei Zhou, Feng Tian, Ji-Chao Wei, Ming-Hui Tai, Fan-Di Meng. Gallbladder Cancer: a Subtype of Biliary Tract Cancer Which is a Current Challenge in ChinaAsian Pacific Journal of Cancer Prevention 2012; 13(4): 1317 doi: 10.7314/APJCP.2012.13.4.1317
126
Ilenia Bartolini, Matteo Risaliti, Laura Fortuna, Carlotta Agostini, Maria Novella Ringressi, Antonio Taddei, Paolo Muiesan. Current management of intrahepatic cholangiocarcinoma: from resection to palliative treatmentsRadiology and Oncology 2020; 54(3): 263 doi: 10.2478/raon-2020-0045
127
Eveline Boucher, Marc Pracht, Catherine Roux, Karim Boudjema, Jean-Luc Raoul. Adjuvant treatment after resection of biliary-tract cancer: yes or no?Oncology Reviews 2010; 4(3): 167 doi: 10.1007/s12156-010-0047-y
128
Dong Kuang, Guo-Ping Wang. Hilar cholangiocarcinoma: Pathology and tumor biologyFrontiers of Medicine in China 2010; 4(4): 371 doi: 10.1007/s11684-010-0130-6
129
Joost W. Wijlemans, Karel J. Van Erpecum, Marnix G.E.H. Lam, Beatrijs A. Seinstra, Maarten L.J. Smits, Bernard A. Zonnenberg, Maurice A.A.J. Van Den Bosch. Trans-arterial 90yttrium radioembolization for patients with unresectable tumors originating from the biliary treeAnnals of Hepatology 2011; 10(3): 349 doi: 10.1016/S1665-2681(19)31549-2
130
Hans Francis Schoellhammer, Yuman Fong, Gagandeep Singh. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set2017; : 818 doi: 10.1016/B978-0-323-34062-5.00051-0
131
Suzanne C. Schiffman, Michael R. Nowacki, Lena Spencer, Kelly M. McMasters, Charles R. Scoggins, Robert C.G. Martin. Molecular factors associated with recurrence and survival following hepatectomy in patients with intrahepatic cholangiocarcinoma: A guide to adjuvant clinical trialsJournal of Surgical Oncology 2014; 109(2): 98 doi: 10.1002/jso.23459
132
Everson L. A. Artifon, Décio Sampaio Couto Júnior, Paulo Sakai. Tratamento endoscópico das lesões biliaresRevista do Colégio Brasileiro de Cirurgiões 2010; 37(2): 143 doi: 10.1590/S0100-69912010000200012
133
Celso Matos, Eva Serrao, Maria Antonieta Bali. Magnetic Resonance Imaging of Biliary TumorsMagnetic Resonance Imaging Clinics of North America 2010; 18(3): 477 doi: 10.1016/j.mric.2010.08.004
134
Hyun-Ho Choi, Ok-Ran Shin, Hyung-Keun Kim, Bu-Seok Jeon, Yong-Won Park, Sang-Woo Kim, Sung-Soo Kim, Hiun-Suk Chae, Soo Vin Lee. Efficacy of Endobiliary Radiofrequency Ablation using a Novel Endoluminal Radiofrequency Ablation Catheter in a Swine ModelJournal of Investigative Surgery 2019; 32(8): 731 doi: 10.1080/08941939.2018.1489566
135
HyungJoo Baik, Sang Hyuk Seo, Kwang Hee Kim, Moon Young Choi, Yo-Han Park, Chang Soo Choi. Treatment of advanced stage cholangiocarcinoma: Systemic therapy may be the starting step for radical surgeryKorean Journal of Clinical Oncology 2018; 14(1): 62 doi: 10.14216/kjco.18011
136
Chiara Raggi, Karim Fiaccadori, Mirella Pastore, Margherita Correnti, Benedetta Piombanti, Elisa Forti, Nadia Navari, Giovanni Abbadessa, Terence Hall, Annarita Destro, Luca Di Tommaso, Massimo Roncalli, Fanyin Meng, Shannon Glaser, Elisabetta Rovida, Caterina Peraldo-Neia, Paula Olaizola, Jesus M. Banales, Alessio Gerussi, Alessandra Elvevi, Michele Droz dit Busset, Sherrie Bhoori, Vincenzo Mazzaferro, Gianfranco Alpini, Fabio Marra, Pietro Invernizzi. Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic CholangiocarcinomaThe American Journal of Pathology 2019; 189(10): 2090 doi: 10.1016/j.ajpath.2019.06.007
137
Sutthiwan Janthamala, Apinya Jusakul, Sarinya Kongpetch, Phongsaran Kimawaha, Poramate Klanrit, Watcharin Loilome, Nisana Namwat, Anchalee Techasen. Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathwayNaunyn-Schmiedeberg's Archives of Pharmacology 2021;  doi: 10.1007/s00210-021-02123-0
138
Omar Hyder, J. Wallis Marsh, Riad Salem, Elena N. Petre, Sanjeeva Kalva, Eleni Liapi, David Cosgrove, Donielle Neal, Ihab Kamel, Andrew X. Zhu, Constantinos T. Sofocleous, Jean-Francois H. Geschwind, Timothy M. Pawlik. Intra-arterial Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Multi-institutional AnalysisAnnals of Surgical Oncology 2013; 20(12): 3779 doi: 10.1245/s10434-013-3127-y
139
Ana F. Brito, Ana M. Abrantes, João C. Encarnação, José G. Tralhão, Maria F. Botelho. Cholangiocarcinoma: from molecular biology to treatmentMedical Oncology 2015; 32(11) doi: 10.1007/s12032-015-0692-x
140
Marco Massani, Luca Bonariol, Tommaso Stecca. Hepatic Arterial Infusion Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma, a Comprehensive ReviewJournal of Clinical Medicine 2021; 10(12): 2552 doi: 10.3390/jcm10122552
141
Keith D. Lillemoe, Michael G. House. Handbook of Liver Disease2012; : 460 doi: 10.1016/B978-1-4377-1725-9.10034-6
142
Ban Seok Lee, Byung Hyo Cha, Eun-Cheol Park, Jaehoon Roh. Risk factors for perihilar cholangiocarcinoma: A hospital-based case-control studyLiver International 2015; 35(3): 1048 doi: 10.1111/liv.12618
143
Young-Ho Kim, Eun-Kyung Hong, Sun-Young Kong, Sung-Sik Han, Seoung-Hoon Kim, Je-Keun Rhee, Soo-Kyung Hwang, Sang-Jae Park, Tae-Min Kim. Two classes of intrahepatic cholangiocarcinoma defined by relative abundance of mutations and copy number alterationsOncotarget 2016; 7(17): 23825 doi: 10.18632/oncotarget.8183
144
Olaguoke Akinwande, Veer Shah, Abigail Mills, Christopher Noda, Eric Weiner, Gretchen Foltz, Nael Saad. Chemoembolization versus radioembolization for the treatment of unresectable intrahepatic cholangiocarcinoma in a single institution image-based efficacy and comparative toxicityHepatic Oncology 2017; 4(3): 75 doi: 10.2217/hep-2017-0005
145
Zhiliang Wu, Thidarut Boonmars, Isao Nagano, Sirintip Boonjaraspinyo, Somchai Pinlaor, Chawalit Pairojkul, Yaovalux Chamgramol, Yuzo Takahashi. Alteration of galectin-1 during tumorigenesis of Opisthorchis viverrini infection-induced cholangiocarcinoma and its correlation with clinicopathologyTumor Biology 2012; 33(4): 1169 doi: 10.1007/s13277-012-0360-0
146
Harsha Moole, Sirish Dharmapuri, Abhiram Duvvuri, Sowmya Dharmapuri, Raghuveer Boddireddy, Vishnu Moole, Prathyusha Yedama, Naveen Bondalapati, Achuta Uppu, Charan Yerasi. Endoscopic versus Percutaneous Biliary Drainage in Palliation of Advanced Malignant Hilar Obstruction: A Meta-Analysis and Systematic ReviewCanadian Journal of Gastroenterology and Hepatology 2016; 2016: 1 doi: 10.1155/2016/4726078
147
Albrecht Reichle, Frank Klebl, Klaus Bross, Frank Kullmann, Peter Wild, Anna Berand, Stefan W. Krause, Jürgen Schölmerich, Reinhard Andreesen. From Molecular to Modular Tumor Therapy2010; : 341 doi: 10.1007/978-90-481-9531-2_16
148
Ivo Boškoski, Tommaso Schepis, Andrea Tringali, Pietro Familiari, Vincenzo Bove, Fabia Attili, Rosario Landi, Vincenzo Perri, Guido Costamagna. Personalized Endoscopy in Complex Malignant Hilar Biliary StricturesJournal of Personalized Medicine 2021; 11(2): 78 doi: 10.3390/jpm11020078
149
Hasaya Dokduang, Anchalee Techasen, Nisana Namwat, Narong Khuntikeo, Chawalit Pairojkul, Yoshinori Murakami, Watcharin Loilome, Puangrat Yongvanit. STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progressionJournal of Hepato-Biliary-Pancreatic Sciences 2014; 21(10): 767 doi: 10.1002/jhbp.131
150
Kengo Shigehara, Shigeki Yokomuro, Osamu Ishibashi, Yoshiaki Mizuguchi, Yasuo Arima, Yutaka Kawahigashi, Tomohiro Kanda, Ichiro Akagi, Takashi Tajiri, Hiroshi Yoshida, Toshihiro Takizawa, Eiji Uchida, Carlo Gaetano. Real-Time PCR-Based Analysis of the Human Bile MicroRNAome Identifies miR-9 as a Potential Diagnostic Biomarker for Biliary Tract CancerPLoS ONE 2011; 6(8): e23584 doi: 10.1371/journal.pone.0023584
151
Manuela Gatto, Maria Consiglia Bragazzi, Rossella Semeraro, Cristina Napoli, Raffaele Gentile, Alessia Torrice, Eugenio Gaudio, Domenico Alvaro. Cholangiocarcinoma: Update and future perspectivesDigestive and Liver Disease 2010; 42(4): 253 doi: 10.1016/j.dld.2009.12.008
152
Ni Wang, Chongguo Zhang, Wulin Wang, Jie Liu, Yang Yu, You Li, Mingjiong Zhang, Xianxiu Ge, Quanpeng Li, Lin Miao. Long noncoding RNA DANCR regulates proliferation and migration by epigenetically silencing FBP1 in tumorigenesis of cholangiocarcinomaCell Death & Disease 2019; 10(8) doi: 10.1038/s41419-019-1810-z
153
T Okusaka, K Nakachi, A Fukutomi, N Mizuno, S Ohkawa, A Funakoshi, M Nagino, S Kondo, S Nagaoka, J Funai, M Koshiji, Y Nambu, J Furuse, M Miyazaki, Y Nimura. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in JapanBritish Journal of Cancer 2010; 103(4): 469 doi: 10.1038/sj.bjc.6605779
154
Caroline D.M. Witjes, Henrike E. Karim‐Kos, Otto Visser, Esther de Vries, Jan N.M. IJzermans, Robert A. de Man, Jan Willem W. Coebergh, Cornelis Verhoef. Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survivalHPB 2012; 14(11): 777 doi: 10.1111/j.1477-2574.2012.00536.x
155
Linqi Guo, Yu Zhou, Ying Chen, Huawei Sun, Yue Wang, Yikun Qu. LncRNA ASAP1-IT1 positively modulates the development of cholangiocarcinoma via hedgehog signaling pathwayBiomedicine & Pharmacotherapy 2018; 103: 167 doi: 10.1016/j.biopha.2018.04.015
156
Kyun Woo Park, Eun-Seon Jung, Dong-Gu Kim, Young-Kyung Yoo, Tae-Ho Hong, In Seok Lee, Yoon Ho Koh, Ji-Hoon Kim, Myung Ah Lee. ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic CholangiocarcinomaCancer Research and Treatment 2013; 45(1): 63 doi: 10.4143/crt.2013.45.1.63
157
Irving Waxman, Mariano Gonzalez-Haba. Difficult Decisions in Hepatobiliary and Pancreatic SurgeryDifficult Decisions in Surgery: An Evidence-Based Approach 2016; : 329 doi: 10.1007/978-3-319-27365-5_29
158
Chang-Sup Lim, Jin-Young Jang, Seung Eun Lee, Mee Joo Kang, Sun-Whe Kim. Reappraisal of Hepatopancreatoduodenectomy as a Treatment Modality for Bile Duct and Gallbladder CancerJournal of Gastrointestinal Surgery 2012; 16(5): 1012 doi: 10.1007/s11605-012-1826-5
159
D Azoulay, G Pascal, C Salloum, R Adam, D Castaing, N Tranecol. Vascular reconstruction combined with liver resection for malignant tumoursBritish Journal of Surgery 2013; 100(13): 1764 doi: 10.1002/bjs.9295
160
Jing Xu, Dajing Li, Xiaowu Li, Zipei Liu, Tianyu Li, Peng Jiang, Qiang He, Feng Tian, Yang Gao, Dechun Wang, Shuguang Wang. 67 laminin receptor promotes the malignant potential of tumour cells up-regulating lysyl oxidase-like 2 expression in cholangiocarcinomaDigestive and Liver Disease 2014; 46(8): 750 doi: 10.1016/j.dld.2014.03.017
161
Tatsuaki Sumiyoshi, Yasuo Shima, Takehiro Okabayashi, Yuji Negoro, Yasuhiro Shimada, Jun Iwata, Manabu Matsumoto, Yasuhiro Hata, Yoshihiro Noda, Kenta Sui, Taijiro Sueda. Chemoradiotherapy for Initially Unresectable Locally Advanced CholangiocarcinomaWorld Journal of Surgery 2018; 42(9): 2910 doi: 10.1007/s00268-018-4558-1
162
R Jeffrey. Multi-Detector CT Imaging2013; : 41 doi: 10.1201/b15604-4
163
In Gyu Hwang, Hong Suk Song, Myung Ah Lee, Eun Mi Nam, Joohan Lim, Kyung Hee Lee, Kyu Taek Lee, Dae Young Zang, Joung-Soon Jang. Treatment outcomes of gemcitabine alone versus gemcitabine plus platinum for advanced biliary tract cancer: a Korean Cancer Study Group retrospective analysisCancer Chemotherapy and Pharmacology 2014; 74(6): 1291 doi: 10.1007/s00280-014-2608-4
164
Haiying Zhao, Fuquan Yang, Wenyan Zhao, Chunjv Zhang, Jingang Liu. Fascin Overexpression Promotes Cholangiocarcinoma RBE Cell Proliferation, Migration, and InvasionTechnology in Cancer Research & Treatment 2016; 15(2): 322 doi: 10.1177/1533034615580696
165
Keun Soo Ahn, Koo Jeong Kang, Yu Na Kang, Yong Hoon Kim, Tae-Seok Kim. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinomaBMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0444-1
166
Mai-Lan Ho, Christine M. Peterson, Vamsidhar R. Narra. Abdominal Imaging2011; : 890 doi: 10.1016/B978-1-4160-5449-8.00086-X
167
Mahesh Kr Goenka, Usha Goenka. Palliation: Hilar cholangiocarcinomaWorld Journal of Hepatology 2014; 6(8): 559-569 doi: 10.4254/wjh.v6.i8.559
168
HAIXIA YANG, JIUPENG ZHOU, XIN WEI, FAN WANG, HUADONG ZHAO, ENXIAO LI. Survival outcomes and progonostic factors of extrahepatic cholangiocarcinoma patients following surgical resection: Adjuvant therapy is a favorable prognostic factorMolecular and Clinical Oncology 2014; 2(6): 1069 doi: 10.3892/mco.2014.377
169
D. Habermehl, K. Lindel, S. Rieken, K. Haase, B. Goeppert, M.W. Büchler, P. Schirmacher, T. Welzel, J. Debus, S.E. Combs. Chemoradiation in patients with unresectable extrahepatic and hilar cholangiocarcinoma or at high risk for disease recurrence after resectionStrahlentherapie und Onkologie 2012; 188(9): 795 doi: 10.1007/s00066-012-0099-y
170
Sun Och Yoon, Tae Joo Jeon, Joon Seong Park, Yong Hoon Ryu, Jae-Hoon Lee, Jung Sik Yoo, Jae Keun Kim, Dong Sup Yoon, Eun Ji Oh. Analysis of the Roles of Glucose Transporter 1 and Hexokinase 2 in the Metabolism of Glucose by Extrahepatic Bile Duct Cancer CellsClinical Nuclear Medicine 2015; 40(3): e178 doi: 10.1097/RLU.0000000000000640
171
Kang Won Lee, Jae Min Lee, Hyuk Soon Choi, Eun Sun Kim, Bora Keum, Yeon Seok Seo, Yoon Tae Jeen, Soon Ho Um, Hong Sik Lee, Hoon Jai Chun, Chang Duck Kim, Chi Hyuk Oh, Hong Bae Kim. Novel Ablation Therapy Using Endoscopic Irreversible Electroporation in the Bile Duct: A Pilot Animal StudyClinical Endoscopy 2021; 54(3): 413 doi: 10.5946/ce.2020.126
172
Jaime Feliu, Javier Sastre, Joan Maurel, Dolores Isla. Hepatocellular and biliary tract carcinomas: SEOM clinical guidelinesClinical and Translational Oncology 2011; 13(8): 536 doi: 10.1007/s12094-011-0694-x
173
C. Damiano Gadaleta, Girolamo Ranieri. Trans-arterial chemoembolization as a therapy for liver tumours: New clinical developments and suggestions for combination with angiogenesis inhibitorsCritical Reviews in Oncology/Hematology 2011; 80(1): 40 doi: 10.1016/j.critrevonc.2010.10.005
174
S. H. Y. Lau, W. Y. Lau. Hilar Cholangiocarcinoma2013; : 187 doi: 10.1007/978-94-007-6473-6_17
175
Ana Brito, Ana Abrantes, Ricardo Teixo, Ana Pires, Ana Ribeiro, Rafael Ferreira, Alexandra Fernandes, Tiago Puga, Mafalda Laranjo, Francisco Caramelo, Ilka Boin, Douglas Jefferson, Ana Gon�alves, Ricardo Martins, Joana Rodrigues, Ilda Ribeiro, Joana Barbosa De Melo, Ana Sarmento-Ribeiro, Isabel Carreira, Doroteia Souza, Jos� Guilherme Tralh�o, Maria Botelho. Iodine‑131 metabolic radiotherapy leads to cell death and genomic alterations through NIS overexpression on cholangiocarcinomaInternational Journal of Oncology 2020;  doi: 10.3892/ijo.2020.4957